Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Kabra Drugs Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹7.19 |
52 Week High | ₹7.19 |
52 Week Low | ₹3.18 |
Beta | -0.45 |
1 Month Change | 0% |
3 Month Change | 10.11% |
1 Year Change | 33.15% |
3 Year Change | 79.75% |
5 Year Change | 1,098.33% |
Change since IPO | 322.94% |
Recent News & Updates
Recent updates
Shareholder Returns
524322 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 0% | 1.4% | 2.8% |
1Y | 33.1% | 57.2% | 46.6% |
Return vs Industry: 524322 underperformed the Indian Pharmaceuticals industry which returned 57.2% over the past year.
Return vs Market: 524322 underperformed the Indian Market which returned 46.6% over the past year.
Price Volatility
524322 volatility | |
---|---|
524322 Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 5.9% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524322 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 524322's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | n/a | Bangalore Venkatakrishnappa Kumar | www.kabradrugs.com |
Kabra Drugs Limited does not have significant operations. Previously, it was engaged in permaculture manufacturing and trading of pharma related products. The company was incorporated in 1989 and is headquartered in Chennai, India.
Kabra Drugs Limited Fundamentals Summary
524322 fundamental statistics | |
---|---|
Market cap | ₹31.55m |
Earnings (TTM) | -₹5.08m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-6.2x
P/E RatioIs 524322 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
524322 income statement (TTM) | |
---|---|
Revenue | ₹0 |
Cost of Revenue | ₹0 |
Gross Profit | ₹0 |
Other Expenses | ₹5.08m |
Earnings | -₹5.08m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -1.16 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | -162.0% |
How did 524322 perform over the long term?
See historical performance and comparison